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The first identified Chikungunya outbreak occurred in Bangladesh in 2008. In late October
2011, a local health official from Dohar Sub-district, Dhaka District, reported an outbreak of
undiagnosed fever and joint pain. We investigated the outbreak to confirm the etiology,
describe the clinical presentation, and identify associated vectors.
Methodology
During November 2–21, 2011, we conducted house-to-house surveys to identify suspected
cases, defined as any inhabitant of Char Kushai village with fever followed by joint pain in
the extremities with onset since August 15, 2011. We collected blood specimens and clini-
cal histories from self-selected suspected cases using a structured questionnaire. Blood
samples were tested for IgM antibodies against Chikungunya virus. The village was divided
into nine segments and we collected mosquito larvae from water containers in seven ran-
domly selected houses in each segment. We calculated the Breteau index for the village
and identified the mosquito species.
Results
The attack rate was 29% (1105/3840) and 29% of households surveyed had at least one
suspected case: 15% had3. The attack rate was 38% (606/1589) in adult women and
25% in adult men (320/1287). Among the 1105 suspected case-patients, 245 self-selected
for testing and 80% of those (196/245) had IgM antibodies. In addition to fever and joint
pain, 76% (148/196) of confirmed cases had rash and 38%(75/196) had long-lasting joint
pain. The village Breteau index was 35 per 100 and 89%(449/504) of hatched mosquitoes
were Aedes albopictus.
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Conclusion
The evidence suggests that this outbreak was due to Chikungunya. The high attack rate
suggests that the infection was new to this area, and the increased risk among adult women
suggests that risk of transmission may have been higher around households. Chikungunya
is an emerging infection in Bangladesh and current surveillance and prevention strategies
are insufficient to mount an effective public health response.
Author Summary
Chikungunya virus is transmitted through bites from Aedesmosquitoes and causes out-
breaks of fever and polyarthralgia; the geographic range of infection is expanding. An out-
break of fever with prolonged joint pain was investigated in Bangladesh in 2011, where
house-to-house surveys were carried out to identify suspected cases. Twenty-nine percent
of the village inhabitants experienced symptoms consistent with Chikungunya during the
three months of the outbreak. Eighty percent of suspected cases had evidence of IgM anti-
bodies against Chikungunya suggesting that this virus caused the outbreak. Attack rates
were similar for all age groups, which suggests that this population had little pre-existing
immunity to the disease. This is consistent with the assumption that Chikungunya is an
emerging infection in this part of the world where the majority of people likely remain sus-
ceptible to infection. Attack rates were higher among adult females, which may provide
clues to where transmission occurs. Since most rural women spend the majority of their
time in and around the home, interrupting vector habitat near houses might be a useful
way to control epidemics. Given the continued risk for outbreaks, we need more efficient
methods for detection and control.
Introduction
Chikungunya is an arthropod-borne disease caused by Chikungunya virus (Alphavirus family,
Togaviridae family) which was initially identified in Tanzania in 1952 [1]. Chikungunya out-
breaks likely happened before the virus was identified because there were many verifiable
depictions of epidemic fevers with remarkable arthralgia [2]. Humans can be a reservoir for
Chikungunya virus during epidemics. In the past 50 years, Chikungunya has re-emerged in
several occasions in both Africa and Asia [3]. Rapid and local transmission of Chikungunya
occurred in the Caribbean and the Americas within 9 months during 2013–2014 [4].Aedes
mosquitoes transmit Chikungunya virus. Aedes aegypti mosquitoes are responsible for trans-
mission of both Chikungunya and dengue [5]and in Asia, have been identified as the primary
vector in most urban dengue epidemics [6].Aedes albopictus was identified as the vector in the
2006 Chikungunya outbreak in La Reunion (an island in the Indian Ocean). This newly identi-
fied vector caused effective replication and spread the infection beyond previously endemic
areas [6].A.albopictus can prosper in both rural and urban environments [7] and breed in artifi-
cial water containers [8].
Since 2005, Chikungunya has become an emerging public health problem in Southeast Asia,
with large numbers of cases reported in Singapore, Malaysia, and Thailand [9]. In 2006, an
increase in the incidence of Chikungunya in India prompted testing of serum samples collected
from febrile patients from two different surveillance projects in Dhaka, Bangladesh. One
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hundred seventy-five serum samples were tested however none had antibodies against Chikun-
gunya virus [10]. In 2008, the first recognized outbreak of Chikungunya in Bangladesh was
identified in the northwest area of the country. Transmission appeared to be geographically
limited to two villages bordering India in northwestern Bangladesh [11].
In late October 2011, an outbreak of fever and severe joint pain was reported by a local
health official in Dohar Sub-district in Dhaka District. Limited antibody testing for dengue and
blood smears for malaria conducted at the local health clinic suggested that the illnesses were
not caused by dengue or malaria. On November 2, 2011, an outbreak investigation team com-
prised of medical epidemiologists, entomologists, field research assistants and laboratory tech-
nicians from the Institute of Epidemiology Disease Control and Research (IEDCR), of the
Bangladesh Ministry of Health and Family Welfare, and icddr,b (formerly known as the Inter-
national Centre for Diarrhoeal Disease Research, Bangladesh) began an investigation with the
objectives of identifying the etiology of the outbreak, describing the clinical presentation of
cases, and identifying associated vectors.
Methods
We focused the investigation in Char Kushai village because a review of the log books from the
local public hospital showed that 70% of the inpatients and outpatients who sought care for
fever and joint pain during May—October 2011 were from that village. We conducted house-
to-house surveys to identify and enlist suspected cases, defined as any inhabitant of Char
Kushai village who reported fever followed by joint pain in the extremities with onset since
August 15, 2011. Local authorities reported that the outbreak had been ongoing since May, but
we limited our suspected case finding efforts to those occurring since August due to concerns
about the ability of residents to reliably recall illnesses for more than a few months.
Patients meeting the suspected case definition were asked to visit the local health clinic to
provide a blood specimen for laboratory testing. Patients who came to the clinic were also
interviewed by the investigation team about their socio-demographic, clinical and travel histo-
ries using a structured questionnaire. Blood was tested in the IEDCR laboratory for IgM anti-
bodies to Chikungunya virus using an antibody enzyme-linked immunosorbent assay (ELISA)
test kit (Bioline Chikungunya IgM manufactured by Standard Diagnostics Inc., Yongin-si,
South Korea). Confirmed cases were defined as suspected cases with IgM antibodies against
Chikungunya. Acute serum collected from patients within 2 days of symptom onset were tested
for using quantitative reverse transcription polymerase chain reaction (RT-qPCR) to identify
Chikungunya virus RNA [12]. We used suspected cases to estimate attack rates by age and gen-
der and described the clinical characteristics of laboratory confirmed cases.
IgM antibodies against Chikungunya typically start to be detected 7 days post-onset of ill-
ness and by two weeks post-onset, nearly all patients will have detectable IgM antibodies.
These persist for approximately 2 months before IgM begins to decline [13–15]. We calculated
the total proportion of patients tested that had IgM antibodies and also for each of these cate-
gories of time since illness onset.
For the entomological investigation, the village was divided into nine segments of approxi-
mately equal areas. Seven households were randomly selected in each segment using household
line listings from the house-to-house survey and larvae were collected during November 2–21
following theWorld Health Organization’s guidelines for vector surveillance [8]. The team
inspected all water containers in and surrounding each selected house, recorded whether larvae
were observed, and collected larvae if present. Larvae were hatched and identified at the IEDCR
entomology lab. The Breteau index (number of positive containers per 100 houses inspected)
was calculated for the village to estimate the mosquito population density in the area [16].
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Ethics
This investigation was carried out as a response to an outbreak investigation and thus the pro-
tocol was not reviewed by a human subjects committee. However, participants provided verbal
informed consent prior to interviews and blood specimen collection and the Government of
Bangladesh approved the outbreak investigation plan.
Results
Data collectors surveyed all 897 households in the village and collected information regarding
symptoms for all 3,840 residents; 1105 (29%) of household members met the suspected case
definition. There were no differences in attack rates by gender among children<10 years of
age; however, females were more likely to report illness than males for every other age group
and the differences were greatest among residents aged 31–40 years (28% of males vs 50% of
females) and 41–50 years (29% vs 53%) (Table 1). Sixty-four percent of households had at least
one suspected case, while 15% had three or more (Table 2).
Twenty-two percent of suspected cases (245/1105) provided blood for testing and 80%
(196/245) of them had IgM antibodies against Chikungunya virus. Suspected cases that selected
for testing were similar in age to those who were not tested, with the exception that fewer chil-
dren aged<10 presented for a blood draw. In addition, cases who sought testing were more
likely to be female than suspected cases who were not tested (Table 3). Patients tested within 1
week of illness onset were unlikely to have IgM antibodies, while 93% of suspected cases tested
between 30 and 60 days post illness onset had IgM antibodies against Chikungunya (Table 4).
Confirmed cases had dates of illness onset from August through November, per the suspected
case definition. One case patient provided a blood sample within 2 days of onset and this
Table 1. Attack rates of suspected Chikungunya fever by age and gender in Char Kushai, Dohar, Ban-
gladesh, August 15–2 November 2011.
Age groups Gender
Male Female
<10 years 93/496 (19%) 86/463 (19%)
10–20 years 72/386 (19%) 102/395 (26%)
21–30 years 52/244 (21%) 139/417 (33%)
31–40 years 56/203 (28%) 157/316 (50%)
41–50 years 53/185 (29%) 114/215 (53%)
51–60 years 46/131 (35%) 50/125 (40%)
> 60 years 41/138 (30%) 44/126 (35%)
Total 413/1783(23%) 692/2057(34%)
doi:10.1371/journal.pntd.0003907.t001
Table 2. Number of suspected cases per household (N = 897) in Char Kushai, Dohar, Bangladesh,
August 15–2 November 2011.
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patient had detectable Chikungunya virus RNA with RT-qPCR; this patient did not have IgM
antibodies in serum.
Thirty-eight percent (75/196) of laboratory confirmed cases reported having joint pain that
persisted for more than one month and 76% (148/196) reported a rash (Table 5). Most rashes
were macular (77%) and involved the face (67%) and upper extremities (53%). Among cases
reporting joint pain, the median number of joints affected was nine (range: 1–14). The most
commonly affected joint was the knee (36%). Joint pain was accompanied by swelling in 29%
of the cases which subsided with the remission of joint pain.
Table 3. Comparing the age and sex of suspected cases who presented to the clinic for antibody test-
ing with suspected cases who were not tested, Char Kushai, Bangladesh, 2011.
Suspected cases tested, N = 245 Suspected cases not tested, N = 860
n(%) n(%)
Age groups (in years)
<10 23 (9) 156 (18)
10–20 33 (14) 141 (16)
21–30 39 (16) 152 (18)
31–40 54 (22) 159 (19)
41–50 47 (19) 120 (14)
51–60 27 (11) 69 (8)
>60 22 (9) 63 (7)
Female 177 (72) 514 (60)
doi:10.1371/journal.pntd.0003907.t003
Table 4. Proportion of suspected patients tested with evidence of IgM antibodies against Chikungu-
nya virus in serum by days since illness onset, Char Kushai, Bangladesh 2011, N = 245.








Table 5. Clinical symptoms of patients who self-selected for laboratory testing and had IgM antibod-
ies against Chikungunya virus in serum in Char Kushai, Dohar, Bangladesh, 2011 (N = 196).
Symptoms n (%)
Fever 196 (100)
Joint pain 196 (100)
Rash 148 (76)
Itching 97 (50)
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Sixty-three houses were inspected for water containers with mosquito larvae, and 252 artifi-
cial and natural containers with water were found and 534 larvae were collected. Eighty-nine
percent of larvae (449/504) that hatched yielded A. albopictusmosquitoes and the remaining
yielded Culex quinquefaciatusmosquitoes. No A. aegyptimosquitoes hatched. The overall Bre-
teau index for the village was 35 per 100.
Discussion
Laboratory findings confirmed that Chikungunya virus caused this outbreak and the clinical
features were consistent with previously described outbreaks [17, 18]. This investigation pro-
vides further evidence that Chikungunya virus has become an emerging public health problem
in Bangladesh [11]. Though no recent community seroprevalence studies of Chikungunya
have been published from Bangladesh or nearby countries, a 1995 cross-sectional survey car-
ried out in Kolkata, which is approximately 250 km from Dhaka, indicated that the level of pre-
vious exposure to Chikungunya infection in that city was low [19]. Chikungunya infection
gives life-long immunity [20], so the consistently high attack rates by age group in our investi-
gation suggest that Chikungunya was new to this geographic area. An abundance of a particu-
lar species of mosquitoes during an outbreak is an important condition for determining the
vector responsible for transmission [21] and the fact that A.albopictus hatched from 89% of the
larvae collected in the village suggests that this vector was likely responsible for transmission
during this outbreak. As A. albopictus has a tendency to breed in water compartments close to
homes and to feed during the day [22], persons who are at home during the day time could be
at increased risk due to prolonged exposure to these mosquitoes. Adult women, most of whom
spend the majority of their day at or very near the home, experienced the highest attack rates in
this outbreak. This finding is similar to outbreaks of Chikungunya in rural areas in other coun-
tries where higher risk among women was also reported [23, 24].
According to WHO, places with a Breteau index>20% have a high risk for dengue out-
breaks [16], and this may be true for other outbreaks of mosquito-borne illness as well. In this
outbreak, the Breteau index was 35%, suggesting risk of transmission of mosquito-borne dis-
ease in Char Kushai was very high. Based on published data on the clinical presentation of Chi-
kungunya, patients’ symptoms usually resolve within a few weeks [25, 26]. However, the joint
pain associated with Chikungunya virus infection can persist for weeks or months, and in
some cases for years [24, 27], resulting insignificant economic burden due to this disability. In
India, the national burden of Chikungunya during the 2006 epidemic was estimated at 25,588
disability adjusted life years (DALYs) lost, with an overall burden of 45.3 DALYs per million
(range 0.01 to 265.6 per million in different states); persistent arthralgia accounted for 69% of
the total DALYs [28]. In this outbreak, 38% of confirmed Chikungunya cases had joint pain
lasting more than one month which increased the burden from the outbreak beyond acute
febrile illnesses it caused. However, the patients who were tested and had their clinical features
assessed during our investigation self-selected for this additional clinical assessment so were
more likely to be severely ill than other suspected cases who did not present for assessment.
This self-selection is the best explanation for why their clinical profile is more severe compared
to other published reports.
This investigation was subject to several limitations. First, four other villages in the sub-
district also reported cases, but we only investigated one village and our findings from Char
Kushai may not be representative of all of the affected areas. Second, we aimed to detect symp-
tomatic illness and did not look for asymptomatic infections. Therefore, we likely underesti-
mated the number of people infected during the outbreak given evidence that 3–25% of
Chikungunya virus infections are asymptomatic [29, 30]. Third, residents may have been
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unable to reliably recall their symptoms or onset of illness, particularly for milder illnesses,
which may have led to an underestimation of suspected cases. Likewise, some suspected cases
may have been missed during the survey. Women, who were almost always interviewed, may
have recalled their own illnesses more than illnesses of adult men in the home so this could
explain some of the variation in attack rates by gender. However, we would expect that women
would be able to recall illnesses among children very well and children were also less likely
than women to report systems consistent with the suspected case definition. Therefore, we
believe that it is unlikely that the gender differences in attack rates are entirely explained by
recall bias.
Resource constraints limited our ability to test all suspected cases for antibodies, and the
diagnostic test we used was imperfect, with 84% sensitivity and 91% specificity during the con-
valescent phase of illness [31]. Therefore, we likely missed some true cases; our analysis show-
ing that patients with recent onset were less likely to have IgM antibodies also suggests that we
preferentially missed true cases if they were tested early in their illness. However, our attack
rates were similar to other confirmed Chikungunya outbreaks and the symptoms exhibited by
confirmed cases were consistent with clinical descriptions of disease from other studies. We
did not collect date of onset data from all suspected cases which limits our ability to describe
the timing of outbreak peaks. The cases who did present for blood draws and data collection
about their illness history self-selected for this data collection and may have been motivated to
participate because they had severe illness. Therefore, our clinical description may overestimate
the severity of infections during this outbreak. The entomologic survey was conducted at the
end of the outbreak; therefore, it is possible that the mosquito species most abundant at the
beginning of the outbreak were different than those that we found at the end. However A. albi-
pictus have been associated in several Chikungunya outbreaks [32], and we found no evidence
of A. aegypti in our survey. It is possible that A.aegypti played a significant role in transmission
at the beginning of outbreak and then disappeared; however, the simplest explanation for our
findings is that A.albopictus were primarily responsible for the outbreak.
This investigation suggests that rural Bangladeshi populations are at risk for emerging mos-
quito-borne diseases, such as Chikungunya. Efforts to improve surveillance and identify out-
breaks more quickly could provide an opportunity for public health action to reduce
transmission, such as mosquito control. However, in rural Bangladesh, no public initiatives are
currently implemented for mosquito control. WHO guidelines suggest that environmental
interventions, such as destroying natural and human-made mosquito breeding sites in and
around homes, may be more cost- effective than chemical methods to kill larva and adult mos-
quitoes [16]. Research to develop and test low-cost methods to identify and respond to out-
breaks of mosquito-borne infections in low-income countries should be explored. Ecological
studies to better describe the spatial and temporal distribution of vector habitats could help
explain why outbreaks in Bangladesh remain geographically limited and could be used to target
interventions in populations at the highest risk for vector-borne diseases.
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